bbc sports football

bbc sports football New York, USA, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Neuroendocrine Tumors Market to Showcase Rapid Growth During the Study Period (2020–2034), at a CAGR of 5.1%| DelveInsight The launch of upcoming therapies such as ITM-11, CAM2029, RYZ101, CABOMETYX, ALPHAMEDIX, and others in the forecast period, rising incident population due to an increased number of endoscopic and radio-imaging studies, increasing research activities are driving neuroendocrine tumor market size. Companies such as Novartis, ITM Solucin GMBH, Camurus, Bristol Myers Squibb, Rayzebio, Exelixis, Ipsen, Takeda, and others are competing fiercely to capture the largest market sizes. DelveInsight’s latest Neuroendocrine Tumors Market Insights report includes a comprehensive understanding of current treatment practices, emerging neuroendocrine tumor drugs, market share of individual therapies, and current and forecasted neuroendocrine tumors market size from 2020 to 2034, segmented into 6MM [the United States, the EU4 (Germany, France, Italy, and Spain), and the United Kingdom]. Key Takeaways from the Neuroendocrine Tumors Market Report According to DelveInsight’s analysis, the market size of neuroendocrine tumors in the US was USD 1.5 billion in 2023. In 2023, Somatostatin analogs (SSAs) captured the highest market size of approximately USD 700 million in the US, followed by LUTATHERA . However, by 2034, radioligand treatments including approved beta emitter-radioligand therapy [LUTATHERA], and most anticipated alpha emitter-based therapies are expected to drive the overall NETs market size. The total number of incident cases of NETs in the US was nearly 29,500 cases in 2023 and is projected to increase by 2034. Prominent emerging companies working in the domain of neuroendocrine tumors, including ITM Solucin GMBH , Camurus , Bristol Myers Squibb , Rayzebio , Exelixis , Ipsen , Takeda , Radiomedix , Orano Med , Perspective Therapeutics , Elicera Therapeutics , Chimerix , Enterome , Teclison , and others, are actively working on innovative neuroendocrine tumor drugs. These novel neuroendocrine tumor therapies are anticipated to enter the neuroendocrine tumors market in the forecast period and are expected to change the market. Some of the key emerging neuroendocrine tumor treatments include ITM-11 (N.C.A. 177LU-EDOTREOTIDE), CAM2029, RYZ101 (ACTINIUM-225 DOTATATE), CABOMETYX (Cabozantinib), ALPHAMEDIX (212PB-DOTAMTATE), [212PB] VMT- -NET , ELC-100 (ADVINCE), ONC201 , EO2401 + NIVOLUMAB , TIRAPAZAMINE (TEC-001) , and others. As the field of radioligand therapy evolves, there is an exciting shift towards alpha-emitting radioisotopes. At present, only beta-emitting radioisotopes are currently approved, companies are now focusing on developing alpha-emitters. In August 2024, Exelixis announced that its supplemental New Drug Application (sNDA) for CABOMETYX has been accepted in the US for: 1) the treatment of adults with previously treated, locally advanced/unresectable or metastatic, well- or moderately differentiated pancreatic neuroendocrine tumors (pNET), and 2) the treatment of adults with previously treated, locally advanced/unresectable or metastatic, well- or moderately differentiated extra-pancreatic NET (epNET). The US Food and Drug Administration (FDA) assigned a standard review with a Prescription Drug User Fee Act (PDUFA) target action date of April 3, 2025. In July 2024 , Curium announced that it had submitted its 505(b)(2) NDA for Lutetium Lu 177 Dotatate Injection for the treatment of somatostatin receptor-positive (SSTR+) GEP-NETS. In April 2024, Novartis announced that the US FDA approved LUTATHERA for the treatment of pediatric patients 12 years and older with SSTR+ GEP-NETs, including foregut, midgut, and hindgut NETs. Discover which therapies are expected to grab the NETs market share @ Neuroendocrine Tumors Market Report Neuroendocrine Tumors Overview Neuroendocrine Tumors (NETs) are a diverse group of cancers that arise from neuroendocrine cells, which have characteristics of both nerve cells and hormone-producing cells. These tumors can develop anywhere in the body but are most commonly found in the gastrointestinal tract, pancreas, and lungs. The exact causes of neuroendocrine tumors are not fully understood, but certain factors may increase risk, including genetic syndromes like multiple endocrine neoplasia type 1 (MEN1), Von Hippel-Lindau disease, and neurofibromatosis. Other potential contributors include chronic inflammatory conditions, smoking, and exposure to certain chemicals. Symptoms of NETs can vary widely depending on the tumor's location and whether it secretes hormones. Some tumors may be asymptomatic for a long time. Common symptoms include abdominal pain, diarrhea, flushing of the skin, unexplained weight loss, and in cases of hormone-secreting tumors, symptoms related to excess hormones, such as changes in blood sugar levels or high blood pressure. Diagnosing NETs typically involves a combination of blood and urine tests to detect hormone levels, imaging studies like CT, MRI, or PET scans, and biopsies to analyze tumor tissue. Specialized tests like chromogranin A (CgA) blood tests or somatostatin receptor scintigraphy (Octreoscan) may also be used to identify neuroendocrine activity and locate tumors. Neuroendocrine Tumors Epidemiology Segmentation The neuroendocrine tumors epidemiology section provides insights into the historical and current neuroendocrine tumors patient pool and forecasted trends for the 6MM. It helps recognize the causes of current and forecasted patient trends by exploring numerous studies and views of key opinion leaders. The neuroendocrine tumors market report proffers epidemiological analysis for the study period 2020–2034 in the 6MM segmented into: Total Incident Cases of NET Cases of NETs by Grade Stage-specific Cases of NET Cases of NETs by Site Cases of NETs by Functional Status Download the report to understand which factors are driving NETs epidemiology trends @ Neuroendocrine Tumors Epidemiological Insights Neuroendocrine Tumors Treatment Market Surgery is generally considered a first-line treatment for localized NETs. The frontline treatment for metastatic disease is somatostatin analogs, and currently, two agents are FDA-approved: SANDOSTATIN (octreotide acetate) and SOMATULINE DEPOT (lanreotide). Both somatostatin analogs provide symptomatic relief in 50% to 70% of patients and biochemical responses in 40% to 60% of patients. Traditionally, mTOR inhibitor – everolimus or sunitinib – was acknowledged as a second-line agent, but with the recent approval of PRRT (peptide receptor radionuclide therapy), the choice of second-line therapy is debatable. While GEP-NETs in children and adolescents are rare, the impact can be devastating. Advanced Accelerator Applications (AAA)/Novartis’s LUTATHERA is now the very first therapy approved specifically for use in pediatric patients with GEP-NETs. offering new hope to young patients living with this rare cancer. In January 2018, the FDA approved LUTATHERA, a radiolabeled somatostatin analog for the treatment of GEP-NETs. In April 2024, Novartis announced that the US FDA approved LUTATHERA for the treatment of pediatric patients 12 years and older with SSTR+ GEP-NETs, including foregut, midgut, and hindgut NETs. LUTATHERA is also approved in Europe for unresectable or metastatic, progressive, well-differentiated (G1 and G2), SSTR-positive GEP-NETs in adults, and in Japan for SSTR-positive NETs. All available therapies for NETs, whether monotherapy or combination, are currently leveraged to treat this complex, diverse population of patients, yet no treatment has maintained progression-free survival (PFS) indefinitely. At present, the NETs market is dominated by SSAs, however, by 2034, radioligand therapies are projected to capture the highest market share, reflecting a paradigm shift driven by their enhanced efficacy and the growing adoption of targeted treatment approaches. While LUTATHERA has primarily been used as a second-line treatment, there is a growing interest in expanding its use to first-line settings for medium- and high-risk NETs. This trend underscores the rising prominence of radioligand therapies in redefining treatment standards in the NETs space. Learn more about the market of NETs @ Neuroendocrine Tumors Treatment Neuroendocrine Tumors Emerging Drugs and Companies Some of the drugs in the pipeline include ITM-11 (ITM Isotope Technologies Munich), CABOMETYX (Exelixis/Ipsen/Takeda), CAM2029 (Camurus), AlphaMedix (Radiomedix/Orano Med), VMT- -NET (Perspective Therapeutics), and others. CABOMETYX (cabozantinib) is a small-molecule inhibitor targeting several receptor tyrosine kinases, such as VEGFRs, MET, RET, and the TAM family (TYRO3, MER, AXL). In August 2024, the FDA accepted a supplemental New Drug Application (sNDA) for cabozantinib to treat patients with advanced pancreatic neuroendocrine tumors (pNET) and extra-pancreatic neuroendocrine tumors (epNET) who have previously undergone treatment. The FDA set a PDUFA target date of April 3, 2025, for review and granted orphan drug designation for pNET. This application is supported by data from the Phase III CABINET trial, which studied CABOMETYX in these patient populations. ITM-11 (177Lu-edotreotide) , developed by ITM Isotope Technologies Munich , is a novel Targeted Radionuclide Therapy that combines two components: Edotreotide (DOTATOC), an octreotide-based somatostatin analog, and EndolucinBeta (n.c.a. lutetium-177 chloride), a low-energy beta-emitting synthetic radioisotope. It is currently under investigation in two Phase III clinical trials: COMPETE (NCT03049189) and COMPOSE (NCT04919226). COMPETE focuses on assessing ITM-11 for treating Grade 1 and Grade 2 GEP-NETs, while COMPOSE investigates its use in patients with well-differentiated high Grade 2 and Grade 3 GEP-NETs. ITM-11 was granted orphan designation for GEP-NET treatment based on Phase II data showing significant improvement in PFS. The other pipeline therapies for neuroendocrine tumors include RYZ101 (ACTINIUM-225 DOTATATE): BRISTOL MYERS SQUIBB/RAYZEBIO CAM2029: Camurus ALPHAMEDIX (212PB-DOTAMTATE): RADIOMEDIX/ORANO MED [212PB] VMT-α-NET: PERSPECTIVE THERAPEUTICS ELC-100 (ADVINCE): ELICERA THERAPEUTICS ONC201: CHIMERIX EO2401 + NIVOLUMAB: ENTEROME TIRAPAZAMINE (TEC-001): TECLISON It is more important than ever to ensure and understand supply chain and manufacturing issues of radiopharmaceuticals to stay at the forefront of radiopharmaceutical innovation, especially since a number of companies are investigating radiopharmaceuticals. Emerging key players should make sure that their product, supply, and production capabilities are adequate, and they should be prepared to meet the challenge of offering new therapeutic approaches to cancer patients who otherwise have limited options. In June 2024, BMS-RayzeBio was forced to pause a phase III trial due to an actinium shortage. Oncolytic virotherapy holds promise for cancer treatment. Oncolytic virotherapies like ELC100 (Elicera Therapeutics) and SVV-001 (Seneca therapeutics) are also being investigated for the treatment of NETs in early clinical trials. The anticipated launch of these emerging therapies are poised to transform the neuroendocrine tumors market landscape in the coming years. As these cutting-edge therapies continue to mature and gain regulatory approval, they are expected to reshape the neuroendocrine tumors market landscape, offering new standards of care and unlocking opportunities for medical innovation and economic growth. To know more about NETs clinical trials, visit @ Neuroendocrine Tumors Treatment Drugs Neuroendocrine Tumors Market Dynamics The neuroendocrine tumors market dynamics are anticipated to change in the coming years. NETs are often diagnosed at an early stage due to the hormonal symptoms they produce, allowing for timely intervention and better outcomes, and with advancements like LUTATHERA being the first therapy specifically approved for pediatric patients with GEP-NETs, along with continued research in targeted therapies such as somatostatin analogs and molecular inhibitors, there are growing opportunities for more effective and personalized treatments ; participation in clinical trials can further drive the discovery of new treatment modalities and improve patient outcomes. Furthermore, many potential therapies are being investigated for the treatment of NETs, and it is safe to predict that the treatment space will significantly impact the NETs market during the forecast period. Moreover, the anticipated introduction of emerging therapies with improved efficacy and a further improvement in the diagnosis rate is expected to drive the growth of the NETs market in the 6MM. However, several factors may impede the growth of the neuroendocrine tumors market. Since most of the NET cases comprise GEP-NETs, the lack of awareness among healthcare professionals and the general public often leads to delayed diagnosis and treatment . GEP-NETs are a heterogeneous group of tumors with diverse clinical presentations, making it difficult to develop standardized treatment protocols. Additionally, challenges in research and development , such as limited funding and resources, hinder advancements in the field, while the complexity of diagnosing GEP-NETs increases the risk of misdiagnosis or delayed diagnosis, resulting in suboptimal treatment outcomes. Moreover, neuroendocrine tumor treatment poses a significant economic burden and disrupts patients’ overall well-being and QOL. Furthermore, the NETs market growth may be offset by failures and discontinuation of emerging therapies , unaffordable pricing , market access and reimbursement issues , and a shortage of healthcare specialists . Scope of the Neuroendocrine Tumors Market Report Neuroendocrine Tumors Therapeutic Assessment: Neuroendocrine Tumors current marketed and emerging therapies Neuroendocrine Tumors Market Dynamics: Conjoint Analysis of Emerging Neuroendocrine Tumors Drugs Competitive Intelligence Analysis: SWOT analysis and Market entry strategies Unmet Needs, KOL’s views, Analyst’s views, Neuroendocrine Tumors Market Access and Reimbursement Discover more about neuroendocrine tumor drugs in development @ Neuroendocrine Tumors Clinical Trials Table of Contents Related Reports Neuroendocrine Tumors Epidemiology Forecast Neuroendocrine Tumors Epidemiology Forecast – 2034 report delivers an in-depth understanding of the disease, historical and forecasted NETs epidemiology in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, Spain) and the United Kingdom, and Japan. Neuroendocrine Tumors Pipeline Neuroendocrine Tumors Pipeline Insight – 2024 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key NETs companies, including RayzeBio, Inc., Seneca Therapeutics, Vyriad, Inc., ADC Therapeutics, Eli Lilly and Company, Biotheus Inc., ImmunityBio, Inc., Chimerix, Merck Sharp & Dohme, Oryzon Genomics S.A., CSPC ZhongQi Pharmaceutical Technology, TaiRx, Inc., Betta Pharmaceuticals, Pfizer, NanOlogy LLC, Cardiff Oncology, Luye Pharma Group, Philogen, Hoffmann-La Roche, Regeneron Pharmaceuticals, among others. Gastroenteropancreatic Neuroendocrine Tumors Market Gastroenteropancreatic Neuroendocrine Tumors Market Insights, Epidemiology, and Market Forecast – 2034 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key GEP-NET companies including Novartis, Ipsen Biopharmaceuticals, Pfizer, ITM Isotopen Technologien Muenchen, Camurus AB, Hutchison Medipharma Limited, Bristol-Myers Squibb, Eisai Limite, Experior S.L., Tarveda Therapeutics, Roche Pharma A, Exelixis, Merck Sharp & Dohme Corp, Recordati Inc, Eli Lilly and Company, Genentech, Inc., Aveo Oncology Pharmaceuticals, Radiomedix, Orano Med, PharmaMar, Bayer, Trio Medicines, among others. Gastroenteropancreatic Neuroendocrine Tumors Pipeline Gastroenteropancreatic Neuroendocrine Tumors Pipeline Insight – 2024 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key GEP-NET companies, including Ascletis, Genexine, PharmAbcine, VAXIMM AG, WPD Pharmaceuticals, Accendatech USA Inc., Midatech Ltd, MediciNova, Kadmon Corporation, LLC, Istari Oncology, Inc., Bristol-Myers Squibb, Novartis, Jiangsu Hengrui Medicine, Peloton Therapeutics, Inc., Karyopharm Therapeutics, VBL Therapeutics, Nerviano Medical Sciences, Acerta Pharma BV, Basilea Pharmaceutica, DNAtrix, Inc., NanoPharmaceuticals LLC, Erasca, Inc., Oblato, Inc., OX2 Therapeutics, Crimson Biopharm Inc., Merck Sharp & Dohme LLC, Transgene, CANbridge Life Sciences Ltd., Eli Lilly and Company, Arcus Biosciences, Inc., Incyte Corporation, BerGenBio ASA, Istari Oncology, Inc., Chimerix, among others. Pancreatic Neuroendocrine Tumors Market Pancreatic Neuroendocrine Tumors Market Insights, Epidemiology, and Market Forecast – 2034 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key PNET companies including Novartis Pharmaceuticals, Pfizer, Keyrus Biopharma, Merck Sharp & Dohme LLC, Pfizer, Apices Soluciones S.L., Pharmacyclics LLC, Ipsen, among others. Oncology Conference Coverage Services DelveInsight’s Oncology Conference Coverage Services offer a thorough analysis of outcomes from major events like ASCO, ESMO, ASH, AACR, ASTRO, SOHO, SITC, the European CAR T-cell Meeting, and IASLC. This detailed examination provides businesses with essential insights for competitive intelligence and market trend forecasting, supporting the formulation of future strategies. Other Business Consulting Services Healthcare Competitive Intelligence Healthcare Licensing Services Healthcare Portfolio Management Case Study Learn how the engagement with respected KOLs bolstered the client's reputation as a leader in the pharma industry at KOL Profiling About DelveInsight DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve . Connect with us on LinkedIn | Facebook | TwitterBuffalo Sabres (10-9-1, in the Atlantic Division) vs. San Jose Sharks (6-11-5, in the Pacific Division) San Jose, California; Saturday, 8 p.m. EST BETMGM SPORTSBOOK LINE: Sabres -166, Sharks +140; over/under is 6 BOTTOM LINE: The San Jose Sharks host the Buffalo Sabres after Alexander Wennberg's two-goal game against the St. Louis Blues in the Sharks' 3-2 shootout loss. San Jose has a 6-11-5 record overall and a 4-4-1 record on its home ice. The Sharks have a -21 scoring differential, with 54 total goals scored and 75 given up. Buffalo is 10-9-1 overall and 4-4-1 on the road. The Sabres serve 10.7 penalty minutes per game to rank third in the league. The teams meet Saturday for the first time this season. TOP PERFORMERS: Tyler Toffoli has nine goals and six assists for the Sharks. Macklin Celebrini has over the last 10 games. Rasmus Dahlin has five goals and 12 assists for the Sabres. Zachary Benson has over the last 10 games. LAST 10 GAMES: Sharks: 3-4-3, averaging 2.4 goals, 4.5 assists, 2.7 penalties and six penalty minutes while giving up 2.6 goals per game. Sabres: 6-4-0, averaging 3.2 goals, 5.5 assists, five penalties and 10.9 penalty minutes while giving up 2.5 goals per game. INJURIES: Sharks: None listed. Sabres: None listed. The Associated Press created this story using technology provided by Data Skrive and data from Sportradar .

NEW YORK , Nov. 25, 2024 /PRNewswire/ -- Osmo , the digital olfaction company, is rethinking how to identify what's real. Today, Osmo launched AI-powered scent sensors, built to authenticate products in ways barcode and RFID (radio frequency identification) tags never could. [Watch Osmo's scent sensor in action here .] Counterfeiting costs retailers and consumers billions of dollars each year. Osmo's sensors work differently than existing authentication technology: they read the unique scent signatures of authentic products, using AI to identify counterfeits with precision and speed. These sensors aren't just a tool—they're a new way to protect trust at scale. Osmo's approach pairs advanced chemical sensors with AI. By training on massive datasets, these sensors recognize subtle scent patterns, ignore background scents, and deliver clear yes-or-no answers in the field. Embedding these sensors in a retailer's supply chains makes authentication faster, simpler, and more reliable. "What's in the air tells the truth," said Alex Wiltschko , CEO and founder of Osmo. "Our AI sensors listen carefully, cutting through noise to confirm authenticity. They work when older methods fall short, helping businesses and customers get what the genuine products they're paying for and deserve—every time." "Counterfeits are just the beginning," said Rohinton Mehta , former Rapid Evaluation and Project Lead at Google X, now SVP of Hardware and Manufacturing at Osmo. "This same system can help ensure food stays fresh, protect the semiconductor supply chain, and even keep data centers running smoothly. The potential is enormous." What Makes Osmo Different? Smarter Sensing: Osmo's sensors are trained to detect the right signals, cutting through background odors to focus on what matters, giving reliable yes-or-no readouts. Osmo offers the first bench of chemical sensors trained using AI. This enhances existing hardware to better recognize patterns, remove background odors, and give reliable, binary yes-or-no readouts in the field. Superior Sensitivity: While humans can detect roughly half of airborne molecules and dogs have a more refined sense of smell, Osmo's sensors detect almost everything in the air, uncovering details others miss. Chemical Fingerprinting: Osmo identifies unique chemical "fingerprints" of substances. This allows it to detect deviations from expected chemical compositions, making it invaluable for quality assurance and security applications. Cost Effectiveness: Osmo provides a scalable and affordable solution for authentication and quality control that fits into real-world workflows. Beyond Authentication: From spotting fake products to ensuring food safety or monitoring air quality, Osmo's sensor technology is designed to adapt. Quality Control: Guaranteeing products meet specific chemical standards. Fraud Detection: Identifying counterfeit or adulterated materials. Chemical Sensing: Detecting specific chemicals in various environments. About Osmo Founded in January 2023 , Osmo launched with $60 million in Series A funding led by Lux Capital and Google Ventures. Osmos's mission is to give computers a sense of smell to improve human health and happiness, combining expertise in AI, chemistry, and engineering to bring scent into the digital age. Osmo has begun work in the fragrance market to create a new generation of better, safer, and more environmentally-friendly scent molecules , designing scent through images or words , and teleporting scent . Beyond fragrance, Osmo is applying its technology in commercial sectors— like detecting counterfeit goods —and public health, where it is discovering new insect repellants . Osmo expects to expand into other industries as the potential for digitized scent grows. Learn more Watch the scent sensor in action: https://youtube.com/shorts/Ce-tEbbpwXo Sign up for the Osmo Community: https://www.osmo.ai/community Press inquiries : [email protected] SOURCE Osmo

WASHINGTON — President-elect Donald Trump said Saturday that he will nominate former White House aide Brooke Rollins to be his agriculture secretary, the last of his picks to lead executive agencies and another choice from within his established circle of advisers and allies. The nomination must be confirmed by the Senate, which will be controlled by Republicans when Trump takes office Jan. 20. Rollins would succeed Tom Vilsack , President Joe Biden’s agriculture secretary who oversees the sprawling agency that controls policies, regulations and aid programs related to farming, forestry, ranching, food quality and nutrition. Then-President Donald Trump looks to Brooke Rollins, president and CEO of the Texas Public Policy Foundation, as she speaks during a Jan. 11, 2018, prison reform roundtable in the Roosevelt Room of the White House in Washington. Rollins, who graduated from Texas A&M University with a degree in agricultural development, is a longtime Trump associate who served as White House domestic policy chief during his first presidency. The 52-year-old is president and CEO of the America First Policy Institute, a group helping to lay the groundwork for a second Trump administration. Rollins previously served as an aide to former Texas Gov. Rick Perry and ran a think tank, the Texas Public Policy Foundation. People are also reading... Mitchell Gold + Bob Williams making furniture in Alexander County again Sheriff: 1 arrested, 1 wanted after Statesville man strangled, robbed Lake Norman residents voice concerns with Marshall Steam Station changes Iredell County bridge to close for $1.2 replacement project Basketball transfer Patterson back home at West Iredell to 'bring in some wins' Believers bought airplane for dead preacher thinking he’d rise from grave to fly in it MerMade: Workspace opens in Statesville, caters to artists, crafters Baseball league cries foul as Iredell plans to charge to use Jennings Park fields Statesville embraces underdog role in rematch with defending champ Hickory With supermajority in NC House gone, Iredell's Republican lawmakers talk changes, challenges Mooresville's Farmer, Graham picked to play in Shrine Bowl Catawba native Christina Eagle appears on season 26 of 'The Voice' Iredell County woman wins first $150,000 top prize in new game Statesville sweeps varsity doubleheader with South Iredell; Shehan reaches 1,000 points in Lake Norman win West Iredell starts season strong with win over Bunker Hill The pick completes Trump’s selection of the heads of executive branch departments, just two and a half weeks after the former president won the White House once again. Several other picks that are traditionally Cabinet-level remain, including U.S. Trade Representative and head of the small business administration. Trump taps Bessent for Treasury, Chavez-DeRemer for labor, Turner for housing FATIMA HUSSEIN, CHRIS RUGABER, JOSH BOAK and CHRIS MEGERIANAssociated Press Rollins, speaking on the Christian talk show “Family Talk" earlier this year, said Trump was an “amazing boss” and confessed that she thought in 2015, during his first presidential campaign, that he would not last as a candidate in a crowded Republican primary field. “I was the person that said, ‘Oh, Donald Trump is not going to go more than two or three weeks in the Republican primary. This is to up his TV show ratings. And then we’ll get back to normal,’” she said. “Fast forward a couple of years, and I am running his domestic policy agenda.” Trump didn’t offer many specifics about his agriculture policies during the campaign, but farmers could be affected if he carries out his pledge to impose widespread tariffs. During the first Trump administration, countries like China responded to Trump’s tariffs by imposing retaliatory tariffs on U.S. exports like the corn and soybeans routinely sold overseas. Trump countered by offering massive multibillion-dollar aid to farmers to help them weather the trade war. Brooke Rollins speaks at an Oct. 27 campaign rally for then-Republican presidential nominee former President Donald Trump at Madison Square Garden in New York. President Abraham Lincoln founded the USDA in 1862, when about half of all Americans lived on farms. The USDA oversees multiple support programs for farmers; animal and plant health; and the safety of meat, poultry and eggs that anchor the nation’s food supply. Its federal nutrition programs provide food to low-income people, pregnant women and young children. And the agency sets standards for school meals. Robert F. Kennedy Jr., Trump’s nominee to lead the Department of Health and Human Services, has vowed to strip ultraprocessed foods from school lunches and to stop allowing Supplemental Nutrition Assistance Program beneficiaries from using food stamps to buy soda, candy or other so-called junk foods. But it would be the USDA, not HHS, that would be responsible for enacting those changes. In addition, HHS and USDA will work together to finalize the 2025-2030 edition of the Dietary Guidelines for Americans. They are due late next year, with guidance for healthy diets and standards for federal nutrition programs. Gomez Licon reported from Fort Lauderdale, Florida. Associated Press writers Josh Funk and JoNel Aleccia contributed to this report. Here are the people Trump has picked for key positions so far President-elect Donald Trump Among President-elect Donald Trump's picks are Susie Wiles for chief of staff, Florida Sen. Marco Rubio for secretary of state, former Democratic House member Tulsi Gabbard for director of national intelligence and Florida Rep. Matt Gaetz for attorney general. Susie Wiles, White House Chief of Staff Susie Wiles, 67, was a senior adviser to Trump's 2024 presidential campaign and its de facto manager. Marco Rubio, Secretary of State Trump named Florida Sen. Marco Rubio to be secretary of state, making a former sharp critic his choice to be the new administration's top diplomat. Rubio, 53, is a noted hawk on China, Cuba and Iran, and was a finalist to be Trump's running mate on the Republican ticket last summer. Rubio is the vice chairman of the Senate Intelligence Committee and a member of the Senate Foreign Relations Committee. “He will be a strong Advocate for our Nation, a true friend to our Allies, and a fearless Warrior who will never back down to our adversaries,” Trump said of Rubio in a statement. The announcement punctuates the hard pivot Rubio has made with Trump, whom the senator called a “con man" during his unsuccessful campaign for the 2016 GOP presidential nomination. Their relationship improved dramatically while Trump was in the White House. And as Trump campaigned for the presidency a third time, Rubio cheered his proposals. For instance, Rubio, who more than a decade ago helped craft immigration legislation that included a path to citizenship for people in the U.S. illegally, now supports Trump's plan to use the U.S. military for mass deportations. Pete Hegseth, Secretary of Defense Pete Hegseth, 44, is a co-host of Fox News Channel’s “Fox & Friends Weekend” and has been a contributor with the network since 2014, where he developed a friendship with Trump, who made regular appearances on the show. Hegseth lacks senior military or national security experience. If confirmed by the Senate, he would inherit the top job during a series of global crises — ranging from Russia’s war in Ukraine and the ongoing attacks in the Middle East by Iranian proxies to the push for a cease-fire between Israel, Hamas and Hezbollah and escalating worries about the growing alliance between Russia and North Korea. Hegseth is also the author of “The War on Warriors: Behind the Betrayal of the Men Who Keep Us Free,” published earlier this year. Pam Bondi, Attorney General Trump tapped Pam Bondi, 59, to be attorney general after U.S. Rep. Matt Gaetz withdrew his name from consideration. She was Florida's first female attorney general, serving between 2011 and 2019. She also was on Trump’s legal team during his first impeachment trial in 2020. Considered a loyalist, she served as part of a Trump-allied outside group that helped lay the groundwork for his future administration called the America First Policy Institute. Bondi was among a group of Republicans who showed up to support Trump at his hush money criminal trial in New York that ended in May with a conviction on 34 felony counts. A fierce defender of Trump, she also frequently appears on Fox News and has been a critic of the criminal cases against him. Kristi Noem, Secretary of Homeland Security Trump picked South Dakota Gov. Kristi Noem, a well-known conservative who faced sharp criticism for telling a story in her memoir about shooting a rambunctious dog, to lead an agency crucial to the president-elect’s hardline immigration agenda. Noem used her two terms leading a tiny state to vault to a prominent position in Republican politics. South Dakota is usually a political afterthought. But during the COVID-19 pandemic, Noem did not order restrictions that other states had issued and instead declared her state “open for business.” Trump held a fireworks rally at Mount Rushmore in July 2020 in one of the first large gatherings of the pandemic. She takes over a department with a sprawling mission. In addition to key immigration agencies, the Department of Homeland Security oversees natural disaster response, the U.S. Secret Service, and Transportation Security Administration agents who work at airports. Doug Burgum, Secretary of the Interior The governor of North Dakota, who was once little-known outside his state, Burgum is a former Republican presidential primary contender who endorsed Trump, and spent months traveling to drum up support for him, after dropping out of the race. Burgum was a serious contender to be Trump’s vice presidential choice this summer. The two-term governor was seen as a possible pick because of his executive experience and business savvy. Burgum also has close ties to deep-pocketed energy industry CEOs. Trump made the announcement about Burgum joining his incoming administration while addressing a gala at his Mar-a-Lago club, and said a formal statement would be coming the following day. In comments to reporters before Trump took the stage, Burgum said that, in recent years, the power grid is deteriorating in many parts of the country, which he said could raise national security concerns but also drive up prices enough to increase inflation. “There's just a sense of urgency, and a sense of understanding in the Trump administration,” Burgum said. Robert F. Kennedy Jr., Secretary of Health and Human Services Robert F. Kennedy Jr. ran for president as a Democrat, than as an independent, and then endorsed Trump . He's the son of Democratic icon Robert Kennedy, who was assassinated during his own presidential campaign. The nomination of Kennedy to lead the Department of Health and Human Services alarmed people who are concerned about his record of spreading unfounded fears about vaccines . For example, he has long advanced the debunked idea that vaccines cause autism. Scott Bessent, Treasury Secretary Scott Bessent, 62, is a former George Soros money manager and an advocate for deficit reduction. He's the founder of hedge fund Key Square Capital Management, after having worked on-and-off for Soros Fund Management since 1991. If confirmed by the Senate, he would be the nation’s first openly gay treasury secretary. He told Bloomberg in August that he decided to join Trump’s campaign in part to attack the mounting U.S. national debt. That would include slashing government programs and other spending. “This election cycle is the last chance for the U.S. to grow our way out of this mountain of debt without becoming a sort of European-style socialist democracy,” he said then. Lori Chavez-DeRemer, Labor Secretary Oregon Republican U.S. Rep. Lori Chavez-DeRemer narrowly lost her reelection bid this month, but received strong backing from union members in her district. As a potential labor secretary, she would oversee the Labor Department’s workforce, its budget and put forth priorities that impact workers’ wages, health and safety, ability to unionize, and employer’s rights to fire employers, among other responsibilities. Chavez-DeRemer is one of few House Republicans to endorse the “Protecting the Right to Organize” or PRO Act would allow more workers to conduct organizing campaigns and would add penalties for companies that violate workers’ rights. The act would also weaken “right-to-work” laws that allow employees in more than half the states to avoid participating in or paying dues to unions that represent workers at their places of employment. Scott Turner, Housing and Urban Development Scott Turner is a former NFL player and White House aide. He ran the White House Opportunity and Revitalization Council during Trump’s first term in office. Trump, in a statement, credited Turner, the highest-ranking Black person he’s yet selected for his administration, with “helping to lead an Unprecedented Effort that Transformed our Country’s most distressed communities.” Sean Duffy, Secretary of Transportation Sean Duffy is a former House member from Wisconsin who was one of Trump's most visible defenders on cable news. Duffy served in the House for nearly nine years, sitting on the Financial Services Committee and chairing the subcommittee on insurance and housing. He left Congress in 2019 for a TV career and has been the host of “The Bottom Line” on Fox Business. Before entering politics, Duffy was a reality TV star on MTV, where he met his wife, “Fox and Friends Weekend” co-host Rachel Campos-Duffy. They have nine children. Chris Wright, Secretary of Energy A campaign donor and CEO of Denver-based Liberty Energy, Write is a vocal advocate of oil and gas development, including fracking — a key pillar of Trump’s quest to achieve U.S. “energy dominance” in the global market. Wright also has been one of the industry’s loudest voices against efforts to fight climate change. He said the climate movement around the world is “collapsing under its own weight.” The Energy Department is responsible for advancing energy, environmental and nuclear security of the United States. Wright also won support from influential conservatives, including oil and gas tycoon Harold Hamm. Hamm, executive chairman of Oklahoma-based Continental Resources, a major shale oil company, is a longtime Trump supporter and adviser who played a key role on energy issues in Trump’s first term. Linda McMahon, Secretary of Education President-elect Donald Trump tapped billionaire professional wrestling mogul Linda McMahon to be secretary of the Education Department, tasked with overseeing an agency Trump promised to dismantle. McMahon led the Small Business Administration during Trump’s initial term from 2017 to 2019 and twice ran unsuccessfully as a Republican for the U.S. Senate in Connecticut. She’s seen as a relative unknown in education circles, though she expressed support for charter schools and school choice. She served on the Connecticut Board of Education for a year starting in 2009 and has spent years on the board of trustees for Sacred Heart University in Connecticut. Brooke Rollins, Secretary of Agriculture Brooke Rollins, who graduated from Texas A&M University with a degree in agricultural development, is a longtime Trump associate who served as White House domestic policy chief during his first presidency. The 52-year-old is president and CEO of the America First Policy Institute, a group helping to lay the groundwork for a second Trump administration. She previously served as an aide to former Texas Gov. Rick Perry and ran a think tank, the Texas Public Policy Foundation. Howard Lutnick, Secretary of Commerce Trump chose Howard Lutnick, head of brokerage and investment bank Cantor Fitzgerald and a cryptocurrency enthusiast, as his nominee for commerce secretary, a position in which he'd have a key role in carrying out Trump's plans to raise and enforce tariffs. Trump made the announcement Tuesday on his social media platform, Truth Social. Lutnick is a co-chair of Trump’s transition team, along with Linda McMahon, the former wrestling executive who previously led Trump’s Small Business Administration. Both are tasked with putting forward candidates for key roles in the next administration. The nomination would put Lutnick in charge of a sprawling Cabinet agency that is involved in funding new computer chip factories, imposing trade restrictions, releasing economic data and monitoring the weather. It is also a position in which connections to CEOs and the wider business community are crucial. Doug Collins, Secretary of Veterans Affairs Doug Collins is a former Republican congressman from Georgia who gained recognition for defending Trump during his first impeachment trial, which centered on U.S. assistance for Ukraine. Trump was impeached for urging Ukraine to investigate Joe Biden in 2019 during the Democratic presidential nomination, but he was acquitted by the Senate. Collins has also served in the armed forces himself and is currently a chaplain in the United States Air Force Reserve Command. "We must take care of our brave men and women in uniform, and Doug will be a great advocate for our Active Duty Servicemembers, Veterans, and Military Families to ensure they have the support they need," Trump said in a statement about nominating Collins to lead the Department of Veterans Affairs. Karoline Leavitt, White House press secretary Karoline Leavitt, 27, was Trump's campaign press secretary and currently a spokesperson for his transition. She would be the youngest White House press secretary in history. The White House press secretary typically serves as the public face of the administration and historically has held daily briefings for the press corps. Leavitt, a New Hampshire native, was a spokesperson for MAGA Inc., a super PAC supporting Trump, before joining his 2024 campaign. In 2022, she ran for Congress in New Hampshire, winning a 10-way Republican primary before losing to Democratic Rep. Chris Pappas. Leavitt worked in the White House press office during Trump's first term before she became communications director for New York Republican Rep. Elise Stefanik, Trump's choice for U.S. ambassador to the United Nations. Tulsi Gabbard, National Intelligence Director Former Hawaii Rep. Tulsi Gabbard has been tapped by Trump to be director of national intelligence, keeping with the trend to stock his Cabinet with loyal personalities rather than veteran professionals in their requisite fields. Gabbard, 43, was a Democratic House member who unsuccessfully sought the party's 2020 presidential nomination before leaving the party in 2022. She endorsed Trump in August and campaigned often with him this fall. “I know Tulsi will bring the fearless spirit that has defined her illustrious career to our Intelligence Community,” Trump said in a statement. Gabbard, who has served in the Army National Guard for more than two decades, deploying to Iraq and Kuwait, would come to the role as somewhat of an outsider compared to her predecessor. The current director, Avril Haines, was confirmed by the Senate in 2021 following several years in a number of top national security and intelligence positions. John Ratcliffe, Central Intelligence Agency Director Trump has picked John Ratcliffe, a former Texas congressman who served as director of national intelligence during his first administration, to be director of the Central Intelligence Agency in his next. Ratcliffe was director of national intelligence during the final year and a half of Trump's first term, leading the U.S. government's spy agencies during the coronavirus pandemic. “I look forward to John being the first person ever to serve in both of our Nation's highest Intelligence positions,” Trump said in a statement, calling him a “fearless fighter for the Constitutional Rights of all Americans” who would ensure “the Highest Levels of National Security, and PEACE THROUGH STRENGTH.” Lee Zeldin, Environmental Protection Agency Administrator Trump has chosen former New York Rep. Lee Zeldin to serve as his pick to lead the Environmental Protection Agency . Zeldin does not appear to have any experience in environmental issues, but is a longtime supporter of the former president. The 44-year-old former U.S. House member from New York wrote on X , “We will restore US energy dominance, revitalize our auto industry to bring back American jobs, and make the US the global leader of AI.” “We will do so while protecting access to clean air and water,” he added. During his campaign, Trump often attacked the Biden administration's promotion of electric vehicles, and incorrectly referring to a tax credit for EV purchases as a government mandate. Trump also often told his audiences during the campaign his administration would “Drill, baby, drill,” referring to his support for expanded petroleum exploration. In a statement, Trump said Zeldin “will ensure fair and swift deregulatory decisions that will be enacted in a way to unleash the power of American businesses, while at the same time maintaining the highest environmental standards, including the cleanest air and water on the planet.” Brendan Carr, Chairman of the Federal Communications Commission Trump has named Brendan Carr, the senior Republican on the Federal Communications Commission, as the new chairman of the agency tasked with regulating broadcasting, telecommunications and broadband. Carr is a longtime member of the commission and served previously as the FCC’s general counsel. He has been unanimously confirmed by the Senate three times and was nominated by both Trump and President Joe Biden to the commission. Carr made past appearances on “Fox News Channel," including when he decried Democratic Vice President Kamala Harris' pre-Election Day appearance on “Saturday Night Live.” He wrote an op-ed last month defending a satellite company owned by Trump supporter Elon Musk. Elise Stefanik, Ambassador to the United Nations Rep. Elise Stefanik is a representative from New York and one of Trump's staunchest defenders going back to his first impeachment. Elected to the House in 2014, Stefanik was selected by her GOP House colleagues as House Republican Conference chair in 2021, when former Wyoming Rep. Liz Cheney was removed from the post after publicly criticizing Trump for falsely claiming he won the 2020 election. Stefanik, 40, has served in that role ever since as the third-ranking member of House leadership. Stefanik’s questioning of university presidents over antisemitism on their campuses helped lead to two of those presidents resigning, further raising her national profile. If confirmed, she would represent American interests at the U.N. as Trump vows to end the war waged by Russia against Ukraine begun in 2022. He has also called for peace as Israel continues its offensive against Hamas in Gaza and its invasion of Lebanon to target Hezbollah. Matt Whitaker, Ambassador to NATO President-elect Donald Trump says he's chosen former acting Attorney General Matt Whitaker to serve as U.S. ambassador to NATO. Trump has expressed skepticism about the Western military alliance for years. Trump said in a statement Wednesday that Whitaker is “a strong warrior and loyal Patriot” who “will ensure the United States’ interests are advanced and defended” and “strengthen relationships with our NATO Allies, and stand firm in the face of threats to Peace and Stability.” The choice of Whitaker as the nation’s representative to the North Atlantic Treaty Organization is an unusual one, given his background is as a lawyer and not in foreign policy. Mike Huckabee, Ambassador to Israel Trump will nominate former Arkansas Gov. Mike Huckabee to be ambassador to Israel. Huckabee is a staunch defender of Israel and his intended nomination comes as Trump has promised to align U.S. foreign policy more closely with Israel's interests as it wages wars against the Iran-backed Hamas and Hezbollah. “He loves Israel, and likewise the people of Israel love him,” Trump said in a statement. “Mike will work tirelessly to bring about peace in the Middle East.” Huckabee, who ran unsuccessfully for the Republican presidential nomination in 2008 and 2016, has been a popular figure among evangelical Christian conservatives, many of whom support Israel due to Old Testament writings that Jews are God’s chosen people and that Israel is their rightful homeland. Trump has been praised by some in this important Republican voting bloc for moving the U.S. embassy in Israel from Tel Aviv to Jerusalem. Steven Witkoff, Special Envoy to the Middle East Trump on Tuesday named real estate investor Steven Witkoff to be special envoy to the Middle East. The 67-year-old Witkoff is the president-elect's golf partner and was golfing with him at Trump's club in West Palm Beach, Florida, on Sept. 15, when the former president was the target of a second attempted assassination. Witkoff “is a Highly Respected Leader in Business and Philanthropy,” Trump said of Witkoff in a statement. “Steve will be an unrelenting Voice for PEACE, and make us all proud." Trump also named Witkoff co-chair, with former Georgia Sen. Kelly Loeffler, of his inaugural committee. Mike Waltz, National Security Adviser Trump asked Rep. Michael Waltz, R-Fla., a retired Army National Guard officer and war veteran, to be his national security adviser, Trump announced in a statement Tuesday. The move puts Waltz in the middle of national security crises, ranging from efforts to provide weapons to Ukraine and worries about the growing alliance between Russia and North Korea to the persistent attacks in the Middle East by Iran proxies and the push for a cease-fire between Israel and Hamas and Hezbollah. “Mike has been a strong champion of my America First Foreign Policy agenda,” Trump's statement said, "and will be a tremendous champion of our pursuit of Peace through Strength!” Waltz is a three-term GOP congressman from east-central Florida. He served multiple tours in Afghanistan and also worked in the Pentagon as a policy adviser when Donald Rumsfeld and Robert Gates were defense chiefs. He is considered hawkish on China, and called for a U.S. boycott of the 2022 Winter Olympics in Beijing due to its involvement in the origin of COVID-19 and its mistreatment of the minority Muslim Uighur population. Stephen Miller, Deputy Chief of Staff for Policy Stephen Miller, an immigration hardliner , was a vocal spokesperson during the presidential campaign for Trump's priority of mass deportations. The 39-year-old was a senior adviser during Trump's first administration. Miller has been a central figure in some of Trump's policy decisions, notably his move to separate thousands of immigrant families. Trump argued throughout the campaign that the nation's economic, national security and social priorities could be met by deporting people who are in the United States illegally. Since Trump left office in 2021, Miller has served as the president of America First Legal, an organization made up of former Trump advisers aimed at challenging the Biden administration, media companies, universities and others over issues such as free speech and national security. Tom Homan, ‘Border Czar’ Thomas Homan, 62, has been tasked with Trump’s top priority of carrying out the largest deportation operation in the nation’s history. Homan, who served under Trump in his first administration leading U.S. Immigration and Customs Enforcement, was widely expected to be offered a position related to the border, an issue Trump made central to his campaign. Though Homan has insisted such a massive undertaking would be humane, he has long been a loyal supporter of Trump's policy proposals, suggesting at a July conference in Washington that he would be willing to "run the biggest deportation operation this country’s ever seen.” Democrats have criticized Homan for his defending Trump's “zero tolerance” policy on border crossings during his first administration, which led to the separation of thousands of parents and children seeking asylum at the border. Dr. Mehmet Oz, Centers for Medicaid and Medicare Services administrator Dr. Mehmet Oz, 64, is a former heart surgeon who hosted “The Dr. Oz Show,” a long-running daytime television talk show. He ran unsuccessfully for the U.S. Senate as the Republican nominee in 2022 and is an outspoken supporter of Trump, who endorsed Oz's bid for elected office. Elon Musk and Vivek Ramaswamy to advise White House on government efficiency Elon Musk, left, and Vivek Ramaswamy speak before Republican presidential nominee former President Donald Trump at an Oct. 27 campaign rally at Madison Square Garden in New York. Trump on Tuesday said Musk and former Republican presidential candidate Ramaswamy will lead a new “Department of Government Efficiency" — which is not, despite the name, a government agency. The acronym “DOGE” is a nod to Musk's favorite cryptocurrency, dogecoin. Trump said Musk and Ramaswamy will work from outside the government to offer the White House “advice and guidance” and will partner with the Office of Management and Budget to “drive large scale structural reform, and create an entrepreneurial approach to Government never seen before.” He added the move would shock government systems. It's not clear how the organization will operate. Musk, owner of X and CEO of Tesla and SpaceX, has been a constant presence at Mar-a-Lago since Trump won the presidential election. Ramaswamy suspended his campaign in January and threw his support behind Trump. Trump said the two will “pave the way for my Administration to dismantle Government Bureaucracy, slash excess regulations, cut wasteful expenditures, and restructure Federal Agencies.” Russell Vought, Office of Management and Budget Russell Vought held the position during Trump’s first presidency. After Trump’s initial term ended, Vought founded the Center for Renewing America, a think tank that describes its mission as “renew a consensus of America as a nation under God.” Vought was closely involved with Project 2025, a conservative blueprint for Trump’s second term that he tried to distance himself from during the campaign. Vought has also previously worked as the executive and budget director for the Republican Study Committee, a caucus for conservative House Republicans. He also worked at Heritage Action, the political group tied to The Heritage Foundation, a conservative think tank. Additional selections to the incoming White House Scavino, whom Trump's transition referred to in a statement as one of “Trump's longest serving and most trusted aides,” was a senior adviser to Trump's 2024 campaign, as well as his 2016 and 2020 campaigns. He will be deputy chief of staff and assistant to the president. Scavino had run Trump's social media profile in the White House during his first administration. He was also held in contempt of Congress in 2022 after a month-long refusal to comply with a subpoena from the House committee’s investigation into the Jan. 6, 2021, attack on the U.S. Capitol. Blair was political director for Trump's 2024 campaign and for the Republican National Committee. He will be deputy chief of staff for legislative, political and public affairs and assistant to the president. Blair was key to Trump's economic messaging during his winning White House comeback campaign this year, a driving force behind the candidate's “Trump can fix it” slogan and his query to audiences this fall if they were better off than four years ago. Budowich is a veteran Trump campaign aide who launched and directed Make America Great Again, Inc., a super PAC that supported Trump's 2024 campaign. He will be deputy chief of staff for communications and personnel and assistant to the president. Budowich also had served as a spokesman for Trump after his presidency. McGinley was White House Cabinet secretary during Trump's first administration, and was outside legal counsel for the Republican National Committee's election integrity effort during the 2024 campaign. In a statement, Trump called McGinley “a smart and tenacious lawyer who will help me advance our America First agenda, while fighting for election integrity and against the weaponization of law enforcement.” Stay up-to-date on the latest in local and national government and political topics with our newsletter.

KitchenAid's viral Evergreen stand mixer keeps selling out, but it's finally back in stock ahead of the holidaysBitget, a global crypto exchange and Web3 firm, is in the process of securing registrations and approvals from the Indian government and aims to open its India office by New Year, COO Vugar Usi Zade told ET . The executive, who was in India last week, mentioned that Bitget has been actively engaging with regulators over the past few months to obtain the necessary approvals for its local operations. In a conversation with ET’s Vinod Mahanta, Zade discusses Bitget’s plans for India, the impact of the Trump presidency on cryptocurrencies, the ongoing bull run, and the evolving role of crypto in a post-AI world. Edited excerpts: Q) Do you think that crypto has a future in countries like India where regulators are not in favour of digital currencies? As a company, we firmly believe that having regulations is far better than having none at all. Recently, I’ve had the opportunity to engage with some regulators in India, as compliance is a key priority for us. Binance has recently secured registration to operate in India and we are looking forward to getting ours from authorities. India, in fact, stands ahead of many other major economies like the US or China, where either crypto is outright banned or faces significant restrictions. While Bitget is still a small player in the Indian market, we are committed to growing responsibly by working closely with regulators to ensure full compliance. The safety and security of customer assets, along with preventing fraud and money laundering, are top priorities for both regulators and companies like ours. We believe that with open dialogue and collaboration, it’s possible to build a regulatory framework that not only ensures safety but also fosters innovation in the crypto space. Artificial Intelligence(AI) Master in Python Language Quickly Using the ChatGPT Open AI By - Metla Sudha Sekhar, IT Specialist and Developer View Program Data Analysis Animated Visualizations with Flourish Studio: Beginner to Pro By - Prince Patni, Software Developer (BI, Data Science) View Program Data Science SQL Server Bootcamp 2024: Transform from Beginner to Pro By - Metla Sudha Sekhar, IT Specialist and Developer View Program Entrepreneurship Boosting Startup Revenue with 6 AI-Powered Sales Automation Techniques By - Dr. Anu Khanchandani, Startup Coach with more than 25 years of experience View Program Web Development Advanced Java Mastery: Object-Oriented Programming Techniques By - Metla Sudha Sekhar, IT Specialist and Developer View Program Office Productivity Advanced Excel Course - Financial Calculations & Excel Made Easy By - Anirudh Saraf, Founder- Saraf A & Associates, Chartered Accountant View Program Leadership Business Storytelling Masterclass By - Ameen Haque, Founder of Storywallahs View Program Entrepreneurship Validating Your Startup Idea: Steps to Ensure Market Fit By - Dr. Anu Khanchandani, Startup Coach with more than 25 years of experience View Program Astrology Vastu Shastra Course By - Sachenkumar Rai, Vastu Shashtri View Program Artificial Intelligence(AI) AI-Powered Python Mastery with Tabnine: Boost Your Coding Skills By - Metla Sudha Sekhar, IT Specialist and Developer View Program Finance Financial Literacy for Non-Finance Executives By - CA Raja, Chartered Accountant | Financial Management Educator | Former AVP - Credit, SBI View Program Artificial Intelligence(AI) Tabnine AI Masterclass: Optimize Your Coding Efficiency By - Metla Sudha Sekhar, IT Specialist and Developer View Program Marketing Digital marketing - Wordpress Website Development By - Shraddha Somani, Digital Marketing Trainer, Consultant, Strategiest and Subject Matter expert View Program Web Development Master RESTful APIs with Python and Django REST Framework: Web API Development By - Metla Sudha Sekhar, IT Specialist and Developer View Program Finance A2Z Of Money By - elearnmarkets, Financial Education by StockEdge View Program Artificial Intelligence(AI) Learn InVideo AI: Create Videos from Text Easily By - Prince Patni, Software Developer (BI, Data Science) View Program Office Productivity Microsoft Word Mastery: From Beginner to Expert By - CA Raj K Agrawal, Chartered Accountant View Program Design Microsoft Designer Guide: The Ultimate AI Design Tool By - Prince Patni, Software Developer (BI, Data Science) View Program Web Development Django & PostgreSQL Mastery: Build Professional Web Applications By - Metla Sudha Sekhar, IT Specialist and Developer View Program Office Productivity Zero to Hero in Microsoft Excel: Complete Excel guide 2024 By - Metla Sudha Sekhar, IT Specialist and Developer View Program Finance Value and Valuation Masterclass By - CA Himanshu Jain, Ex McKinsey, Moody's, and PwC, Co - founder, The WallStreet School View Program Web Development Intermediate Java Mastery: Method, Collections, and Beyond By - Metla Sudha Sekhar, IT Specialist and Developer View Program India holds immense potential for crypto, and we’re excited to be part of this journey, ensuring that we serve the Indian customer in the best and safest way possible. Discover the stories of your interest Blockchain 5 Stories Cyber-safety 7 Stories Fintech 9 Stories E-comm 9 Stories ML 8 Stories Edtech 6 Stories Q. What are Bitget’s plans in India? India is a key market for us, both in terms of talent and operations. We are actively setting up a local office and hiring the necessary team members, including legal and operational staff, to ensure compliance and efficient operations. Our goal is to establish a strong local presence, moving beyond a globally managed front-facing approach to a more localised operation. India, with its vast population of 1.4 billion people, presents a massive opportunity. Currently, we serve 45 million users globally, so there’s significant potential for growth here. This means not only expanding our services but also investing in more manpower and infrastructure to cater to the Indian market effectively. Initially, we plan to leverage builders and interns to establish our presence in various markets. Over time, as we grow and understand the market better, we’ll expand to a full-time team to manage operations locally. However, our hiring and investment trajectory will depend heavily on how the market evolves. All large players are registered themselves in India and competition will be fierce. Crypto markets are inherently cyclical, and factors like the duration of the current bullish cycle or the onset of another crypto winter could significantly influence our growth plans. That said, with rising competition among global players aiming for a foothold in India, we are committed to making a strong entry and adapting to the dynamics of this promising market. Q. How many users do you currently have in India? At the moment, we have around 65,000 users in India. This number has remained relatively modest because we have not actively operated in the market until recently. Additionally, due to the licensing process, we temporarily paused onboarding Indian users. However, once we secure the necessary approvals and ensure compliance, we are prepared to begin onboarding Indian users again. Our timeline for fully operationalising in India depends on the compliance green light, but we are making significant progress in our discussions. Ideally, we aim to start operations before the end of the year, and we are already in the process of setting up a local office, which should be functional before the new year. By the first quarter of next year, we expect to be in a strong position to expand our presence and serve Indian users more effectively. Q. Rules for crypto assets remain inconsistent across the world. French lawmakers are debating a tax on unrealised capital gains for cryptocurrencies. What are your thoughts on this? The approach of taxing unrealised gains is definitely controversial and, in my opinion, flawed. It reminds me of how regulators handled data privacy after the Facebook-Cambridge Analytica scandal. Before that, there were no significant regulations around user data, but post-scandal, Europe introduced GDPR. While well-intentioned, it ended up being more about creating layers of compliance than truly solving the root issues of data misuse. Similarly, I fear that crypto regulations could become more about revenue generation or control than serving the best interests of end-users or fostering innovation. In Europe, unfortunately, crypto holders and companies are increasingly seen as cash cows. We've seen examples like the UK introducing a 36% capital gains tax, and now discussions about taxing unrealised gains in France. This approach feels inconsistent with broader financial practices. For instance, in the stock market, you wouldn't tax Elon Musk or other major investors for their unrealised gains—taxation applies only when gains are realised. It should be no different for crypto assets. Additionally, taxing during a bull run without considering the cyclical nature of the market is short-sighted. Crypto markets are notoriously volatile; if governments want to tax gains during a rally, will they also refund or compensate investors for losses during a downturn? Such policies lack balance and could discourage participation in the crypto ecosystem. That said, regulators are not entirely unaware—they understand that crypto markets are cyclical and see the bull runs as opportunities to generate revenue quickly. But for a sustainable crypto economy, we need balanced and fair regulations that promote growth and innovation while protecting stakeholders, not just opportunistic tax policies. Q. Do you think the election of President Trump could be a turning point for crypto? I hope it is, he is a business and he can smell money. The election of President Trump could indeed mark a significant moment for the crypto industry, potentially signalling a shift in how the United States approaches this space. While his recent comments on BRICS and their plans for a new currency highlight his concerns over the US dollar's dominance, this very anxiety could push him to view cryptocurrencies like Bitcoin as strategic assets to reinforce the United States' position on the global financial stage. Trump, being a businessman, may recognise the opportunity that cryptocurrencies offer. For instance, the US government could theoretically use its ability to print dollars to acquire Bitcoin or other assets, reinforcing its stake in the crypto ecosystem. This would not only elevate the market but also re-establish the US as a leader in the space, which has seen a significant exodus of crypto companies over the past few years due to regulatory challenges. The US's strict regulatory environment has driven major crypto players to relocate to regions like the Middle East and Asia. Events like Consensus, once a cornerstone of the crypto industry, have shifted to Hong Kong, underscoring how the US is losing its foothold in the global crypto landscape. A Trump administration might reverse this trend by adopting a more business-friendly and strategic stance. That said, while Trump might create opportunities for the crypto industry, he is also likely to see cryptocurrencies as a potential revenue stream for the government. Increased taxes on crypto gains could be a part of his approach to demonstrate economic benefits for the American people. Overall, Trump’s presidency could bring both opportunities and challenges, but it has the potential to realign the US's position in the global crypto market. Q. Why are Dubai and UAE becoming crypto hubs? Dubai has become a significant hub for the crypto industry, and several factors contribute to this shift. First, Dubai’s zero-tax policy, especially on personal gains, is a major attraction for entrepreneurs and investors. For many, it offers a more favourable environment compared to the heavy taxation in regions like Europe, the UK, or India. This financial advantage is a key driver for businesses and individuals relocating there. Second, Dubai has positioned itself as an entrepreneurial hub, with a strong influx of venture capital and investment opportunities. While the UAE may not rank among the top 10 or 20 economies for retail crypto adoption or payment use, its entrepreneurial ecosystem makes it a "hot heart" for innovation. For example, we’re seeing oil companies in the region start leveraging crypto, particularly USDT transfers, for fast, cost-effective transactions that bypass the traditional banking system. Another significant factor is the UAE government's progressive stance on crypto. They’ve been open to embracing it as a legitimate form of payment, including legalising salary payments in crypto. This openness, combined with the ease of setting up a business in Dubai, where licensing and compliance take as little as four to six months, makes it a highly attractive destination for crypto ventures. In contrast, other regions like Europe, the US, or even India have more complex regulatory frameworks, making it harder to set up and operate a compliant crypto business. Dubai's straightforward and proactive approach to regulation has given it a significant competitive edge. Finally, there’s an underlying concern among Indian crypto users about the safety of their investments, given the uncertainty in regulatory policies. This has driven many Indian crypto players to consider Dubai as a safer and more stable alternative for operations and investments. Q. After the WazirX hack, Indian investors have been increasingly doubtful about the safety of their money in Indian exchanges. What safety measures does your exchange have in place? Operating at a global level allows us to implement diverse safety protocols and maintain broader liquidity pools, making it much harder for a single breach to compromise the system. Additionally, we’ve established one of the largest Protection Funds in the crypto industry, valued at approximately $600 million. This fund, primarily held in Bitcoin, is stored in publicly accessible wallets, ensuring complete transparency. Users can verify the fund’s existence and availability at any time. The Protection Fund acts as a safety net for our customers. In the rare event of technical issues or if funds are lost due to an exchange error, we use this fund to compensate users. This level of assurance is something most local exchanges cannot offer, as maintaining such substantial reserves requires significant resources and operational scale. Another layer of safety comes from reduced market volatility. Global exchanges like ours benefit from larger liquidity pools and advanced market-making capabilities, ensuring more stable prices and minimising risks like arbitrage or price swings, which are common on smaller, localised platforms. Q. Bitcoin touched $100,000 recently. How long do you think this bull run will last? Ideally, I hope this bull run lasts longer than we anticipate. Based on my personal predictions, we have seen Bitcoin hit $100,000. It could potentially pull back to around $70,000, and then make another surge to $150,000 before the cycle ends. However, several factors will influence the duration and strength of this bull run. A significant driver will be what happens after President Trump’s inauguration in January and how the US government manages its monetary policy. If there’s an increase in liquidity, with more dollars entering the system, we could see greater investments in Bitcoin, especially from institutional players. Additionally, the performance of the US economy and unemployment rates could push ETF holders like BlackRock and others to channel more funds into Bitcoin-focused ETFs, adding further momentum. Outside of the US, global developments are also playing a crucial role. In Russia, for example, recent legislation recognises crypto as property and allows payments in crypto. Such regulatory shifts could drive more capital into the market. Similarly, Apple’s recent collaboration with Ripple to enable crypto payments through Apple Pay could be a game changer. If Apple leads the way, other major mobile players are likely to follow, bringing more retail users into the crypto ecosystem. If these developments unfold back-to-back in the first half of the next year, we could see the bull run extend, potentially onboarding the next billion users into crypto. However, this optimism is tempered by the unpredictability of global events. Factors like Trump’s age and health, or geopolitical uncertainties such as wars, could disrupt the momentum. Ultimately, this bull run represents an exciting time for the mainstream adoption of crypto, but its length and impact will depend on how these factors align in the coming months. Q.: A lot of Indian crypto investors have lost money after investing in dubious tokens. How do crypto invest safely in alt coins? I want to be very frank—it's not just altcoins and meme coins; schemes like MLM structures, lotteries, and fortune games are extremely popular in India. It’s no secret why: there’s a high concentration of people looking to get rich quickly, and these promises appeal to that mindset. The narrative of someone putting $100 into something and becoming a millionaire overnight is incredibly alluring. But honestly, it’s not a trading strategy or an investment strategy. It’s about chasing a fortune, often driven by hope. Many times, these individuals are putting in their last $20 or $30, and it creates a chain reaction. It’s often friends or family who start with $100, double it to $200, then decide to put in $400 to make it $800—and so on. This pattern is common in almost all developing economies, especially where a significant portion of the population lives around the poverty line. That’s what makes these schemes thrive. It’s interesting how these schemes manage to attract people to come and play around. Unfortunately, this often turns into more of a gambling mindset—throwing money into something without any understanding or proper research. It’s one of the most unfortunate aspects of this space. We’ve seen this happen with cases like OneCoin and other big MLM-style structures. Most of these schemes don’t even have anything to do with the actual crypto industry or blockchain technology. They simply ride on the narrative that everyone hears in the media about Bitcoin and crypto. Then, someone comes up with a "new crypto" that promises to make people rich overnight, and individuals end up investing whatever little they have, driven by hope for a better future. It’s a cycle of misplaced trust and a lack of awareness. Q. Critics of crypto argue that it lacks practical use cases and real utility, dismissing it as mere speculative asset. What’s your perspective on this? I think most projects, especially these meme tokens, have zero utility—and they don’t even claim to have any. They aim to be more of a cultural moment, and honestly, I agree that it’s a very Gen Z phenomenon. Whether we like it or not, most jobs and wealth in the world are still held by Boomers. Lifespans are getting longer, these people aren’t retiring, and that leaves fewer opportunities for Gen Z. Buying a home, for example, is nearly impossible for anyone starting out today on an entry-level salary. So, it makes sense that everyone’s looking for a way to make money. For Gen Z, meme tokens often feel like the only shot at becoming a millionaire. For many young people, achieving that kind of wealth through a corporate job is practically impossible, so I understand why they’re drawn to these tokens. That said, as someone who’s been in the tech industry for seven or eight years, I strongly believe that having real utility is crucial. But if we’re being honest, even Bitcoin has limited utility when you look closely. Bitcoin transactions are so expensive now that they’re impractical for everyday use—like buying coffee—unless you use sidechains. In that sense, Bitcoin itself doesn’t have much utility either, except as a store of value. Its value today comes largely from institutional adoption and ETFs, which have cemented its role as a medium of exchange. But we can say the same about global fiat currencies. They’re issued by central banks, and we trust them because of consensus. Yet they’re far from infallible—currencies get devalued all the time, governments wipe zeros off the end, and inflation erodes their worth. At the end of the day, it all runs on a consensus mechanism. So, if there’s a larger consensus around something—whether it’s Bitcoin, a meme token, or even fiat currency—then why not? That’s just how value works in any system. Q: What will be the role of crypto in post-AI world? I think there are two key aspects to consider. First, blockchain as a technology has immense potential for AI. One of AI’s biggest challenges today is the need to distinguish between human-created data and AI-generated data. This often leads to messy and blurred distinctions. In the future, I believe blockchain can play a crucial role by ensuring that any information created by humans is stored on-chain to verify its authenticity. Similarly, putting AI-generated data on-chain will help machines differentiate between human-created and AI-created content, maintaining clarity about what constitutes original data. This makes blockchain an essential infrastructure for the AI industry. On the other hand, if we consider the current hype around crypto and AI, it’s clear that AI has gained significant traction. For instance, OpenAI recently raised $6.6 billion—one of the largest fundraises we’ve ever seen. By comparison, the blockchain industry hasn’t seen anything on that scale. AI’s widespread applications in daily life are largely uncontroversial, as it helps large corporations and enhances efficiency without challenging the status quo. In contrast, crypto has always been positioned as a disruptor, particularly in traditional financial systems, which is why it has faced more resistance and regulatory hurdles. Looking ahead, I believe AI and crypto can coexist without conflicting. We’re already seeing more companies treat crypto as just another payment option, similar to Apple Pay or Samsung Pay. Visa, Mastercard, and bank transfers coexist with crypto-backed solutions like Bitget Cards, which I’m particularly proud of. These cards are crypto-backed but work seamlessly on Visa’s processing network, showing how crypto can integrate with existing systems instead of trying to replace them entirely. Sometimes, building on what already exists is a better approach than attempting to destroy and rebuild everything from scratch. This way, we can innovate while keeping the system familiar and functional for everyone.

Former treasurer Josh Frydenberg has demanded an end to the Albanese’s government’s “weakness” on antisemitism but welcomed the Prime Minister’s response to the Melbourne firebombing of the Adass Israel Synagogue. The firebombing of the Melbourne synagogue on Friday led to an immediate call from Mr Frydenberg to Mr Albanese to take action against rampant antisemitism in the country by declaring the attack on Friday a terrorist event. Following scathing criticism from the Jewish community and the Coalition, Mr Albanese labelled the recent synagogue firebombing as a “terrorist attack”. Mr Frydenberg said he welcomed the Prime Minister’s comments on the attack, but noted it had come "after the fact". The former treasurer said over the past 14 months the Albanese government has shown “weakness” in combatting antisemitism which had become “emboldened” on campuses and throughout the streets. “Enough is enough because we cannot have Jewish students feeling unsafe on campus. We need a judicial inquiry into antisemitism on campus, which should be houses of learning but have become hotbeds of hate,” Mr Frydenberg told Sky News host Peter Stefanovic. “We need a national police task force not to deal with other forms of hate, but to deal with anti-Semitism, because that is what predominantly we have seen across our country over the last 14 months. “We also need the state premiers to restrict and ban demonstrations of the kind that we've seen outside places of worship, whether they're a church, whether they're a mosque, whether they're a temple or whether they are a synagogue.” NSW Premier Chris Minns has called for a review of laws to prevent the targeting of places of worship following the heinous firebombing of the Adass Israel Synagogue. “I’ve asked the Attorney-General and the cabinet office to look at ways we can better protect places of worship from protests and provide reform options to the government,” Mr Minns said. The potential laws would regulate protesting outside of religious institutions which seeks to intimidate worshippers. The Premier said “holding the line” was no longer feasible and the government needed to make sure the freedom of religion was “protected”. Mr Frydenberg also acknowledged how demonstrations outside the Great Synagogue in Sydney last week had left people terrified as locked themselves inside. “Enough is enough, Prime Minister,” the former treasurer said on Monday. “No more words. We want to see concrete action. “It needs more than calling it out. It needs stamping it out.” After the synagogue firebombing, Mr Frydenberg stressed his focus was not on Israel, but Australia and becoming the country “we want to be and not what we’ve become". “Once social cohesion has broken down it is only a matter of time before another community is next. This is why the attack on Adass was not an attack on one it was an attack on all,” he said on Saturday.

PNC Financial Services Group Inc. Reduces Stake in Texas Roadhouse, Inc. (NASDAQ:TXRH)In a surprising turn despite financial setbacks, Bill Sweeney, the chief executive of the Rugby Football Union (RFU), has received a significant pay rise of over £400,000, bringing his total remuneration to £1.1 million. This comes in the wake of a reported record operating loss of £37.9 million for the RFU, a drastic shift from the previous year's profit of £4 million. The annual report highlights RFU revenues totaling £175.2 million, down from £221.4 million the prior year, amidst continued investments in rugby. The RFU has also revealed the anticipated financial effects of the Rugby World Cup, maintaining a robust financial strategy with no debt and positive reserves, according to RFU Board Chairman Tom Ilube. Despite the financial strains, Sweeney emphasized stability within the community game, with increased player registrations reported, and predicted a transformative impact from a new £100 million sponsorship deal with Allianz, particularly as the union prepares to host the Women's Rugby World Cup 2025. (With inputs from agencies.)